Clinical Trials

731 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00040183 2018-01-10

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

569 enrolled

Pancreatic Neoplasms

NCT01351415 2017-09-18

A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

485 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT02178397 2017-07-17

FLARE

6 enrolled

Lung Neoplasms

NCT01360554 2017-05-24

ARCHER 1009

878 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung

NCT02694536 2017-03-24

A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

80 enrolled 10 charts

Pancreatic Neoplasms

NCT02031744 2017-03-14

A Study of the Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer

530 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01024413 2017-03-01

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

256 enrolled

Lung Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

NCT02795884 2016-12-30

Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation

Phase 3 Withdrawn

Lung Neoplasms

NCT01377376 2016-12-07

ATTENTION

Carcinoma, Non-Small-Cell Lung

NCT00412217 2016-11-25

A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer

94 enrolled 6 charts

Head & Neck

Head and Neck Neoplasms

NCT01456325 2016-11-02

A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

494 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01887886 2016-11-02

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

10 enrolled

Non-Squamous Non-Small Cell Lung Cancer

NCT01328951 2016-10-28

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

643 enrolled 16 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01887795 2016-08-25

Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as ﬁrst-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study

224 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00257608 2016-04-18

A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)

1,145 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00349219 2016-01-15

TORCH

760 enrolled

Advanced Non-Small Cell Lung Cancer

NCT00883779 2015-12-14

A Study of Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

451 enrolled 23 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00265824 2015-12-11

DREAM

700 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00634725 2015-12-11

Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

820 enrolled

Pancreatic Neoplasms

NCT00738881 2015-10-29

MARVEL

23 enrolled 4 charts

Carcinoma, Non-Small-Cell Lung

NCT00373425 2015-09-17

RADIANT

1,252 enrolled 24 charts